Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Finley John David Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 4 Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.
Txns: Paid exercise price by delivering 397 shares @ $0.5501, valued at $218.4
Exercised 1,309 options to buy @ $0
09/29/2023 4 Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.
Txns: Bought 15,000 shares @ $0.5392, valued at $8.1k
08/14/2023 4 Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.
Txns: Paid exercise price by delivering 1,040 shares @ $0.7, valued at $728
Exercised 3,475 options to buy @ $0
07/06/2023 4 Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.
Txns: Paid exercise price by delivering 389 shares @ $1.764, valued at $686.2
Exercised 1,309 options to buy @ $0
04/05/2023 4 Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.
Txns: Paid exercise price by delivering 435 shares @ $2.01, valued at $874.4
Exercised 1,309 options to buy @ $0
02/08/2023 4 Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.
Txns: Granted 41,700 options to buy @ $0
Granted 32,500 options to buy @ $0
Granted 57,200 options to buy @ $2.4, valued at $137.3k
01/06/2023 4 Finley John David (CEO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Granted 5,236 options to buy @ $0
09/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/02/2022 4 Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Acquired 12,545 shares @ $0
03/25/2022 4 Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Bought 7,500 shares @ $1.0899, valued at $8.2k
02/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2022 4 Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Granted 178,091 options to buy @ $2.32, valued at $413.2k
09/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/29/2021 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy